Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (11): 1223-1226.doi: 10.3969/j.issn.1000-6621.2019.11.014
• Review Articles • Previous Articles Next Articles
Received:
2019-09-24
Online:
2019-11-10
Published:
2019-12-05
MU Cheng,WANG Chun-hua. Progress on the application of matrix-assisted laser desorption ionization-time of flight mass spectrometry in the field of tuberculosis research[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1223-1226. doi: 10.3969/j.issn.1000-6621.2019.11.014
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.11.014
[1] |
Domon B, Aebersold R . Mass spectrometry and protein analysis. Science, 2006,312(5771):212-217.
doi: 10.1126/science.1124619 URL pmid: 16614208 |
[2] |
Singhal N, Kumar M, Kanaujia PK , et al. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol, 2015,6:791.
doi: 10.3389/fmicb.2015.00791 URL pmid: 26300860 |
[3] |
Diamandis EP . Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics, 2004,3(4):367-378.
doi: 10.1074/mcp.R400007-MCP200 URL pmid: 14990683 |
[4] |
Mesaros C, Blair IA . Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease. Clin Proteomics, 2016,13:20.
doi: 10.1186/s12014-016-9121-1 URL pmid: 27713681 |
[5] |
Bowlus CL, Seeley EH, Roder J , et al. In situ mass spectrometry of autoimmune liver diseases. Cell Mol Immunol, 2011,8(3):237-242.
doi: 10.1038/cmi.2010.72 URL pmid: 21258365 |
[6] |
World Health Organization . Global tuberculosis report 2018. Geneva: World Health Organization, 2018.
doi: 10.1080/21645515.2019.1693720 URL pmid: 31730397 |
[7] |
Cao Y, Wang L, Ma P , et al. Accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of mycobacteria: a systematic review and meta-analysis. Sci Rep, 2018,8(1):4131.
doi: 10.1038/s41598-018-22642-w URL pmid: 29515167 |
[8] | 李松, 姚妍娇, 屈平华 , 等. 基质辅助激光解析电离飞行时间质谱技术对非结核分枝杆菌的鉴定与分型. 中华检验医学杂志, 2018,41(2):109-115. |
[9] |
Şamlı A , I ˙ lki A. Comparison of MALDI-TOF MS, nucleic acid hybridization and the MPT64 immunochromatographic test for the identification of M.tuberculosis and non-tuberculosis Mycobacterium species . New Microbiol, 2016,39(4):259-263.
URL pmid: 27551724 |
[10] |
Singh A, Gopinath K, Sharma P , et al. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant. Indian J Med Res, 2015,141(1):27-45.
doi: 10.4103/0971-5916.154492 URL pmid: 25857493 |
[11] |
Lata M, Sharma D, Kumar B , et al. Proteome analysis of ofloxacin and moxifloxacin induced Mycobacterium tuberculosis isolates by proteomic approach. Protein Pept Lett, 2015,22(4):362-371.
doi: 10.2174/0929866522666150209113708 URL pmid: 25666036 |
[12] |
Sharma D, Kumar B, Lata M , et al. Comparative proteomic analysis of aminoglycosides resistant and susceptible Mycobacterium tuberculosis clinical isolates for exploring potential drug targets. PLoS One, 2015,10(10):e0139414.
doi: 10.1371/journal.pone.0139414 URL pmid: 26436944 |
[13] |
Li C, He X, Li H , et al. Discovery and verification of serum differential expression proteins for pulmonary tuberculosis. Tuberculosis (Edinb), 2015,95(5):547-554.
doi: 10.1016/j.tube.2015.06.001 URL pmid: 26276261 |
[14] | 陈汐濛, 贾兴旺, 雷红 , 等. 应用基质辅助激光解吸电离飞行时间质谱行骨关节结核血清鉴别标志物的初探. 中华检验医学杂志, 2019,42(6):420-426. |
[15] |
Caws M, Thwaites G, Dunstan S , et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog, 2008,4(3):e1000034.
doi: 10.1371/journal.ppat.1000034 URL pmid: 18369480 |
[16] | 周莹, 黄迪迪, 何丹 , 等. SP110基因rs11679983A/G多态性与中国南方汉族肺结核易感性研究. 中华医院感染学杂志, 2016,26(7):1477-1479. |
[17] |
汪文斐, 张国良, 杨帆 , 等. 飞行时间质谱与TaqMan探针技术在结核病易感性相关基因单核苷酸多态性筛选中的应用. 中国防痨杂志, 2014,36(6):434-439.
doi: 10.3969/j.issn.1000-6621.2014.06.006 URL |
[18] |
Bragina EY, Babushkina NP, Garaeva AF , et al. Impact of the Polymorphism of the PACRG and CD80 Genes on the Development of the Different Stages of Tuberculosis Infection. Iran J Med Sci, 2019,44(3):236-244.
URL pmid: 31182890 |
[19] |
Caprioli RM, Farmer TB, Gile J . Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem, 1997,69(23):4751-4760.
doi: 10.1021/ac970888i URL pmid: 9406525 |
[20] |
Vestal M, Li L, Dobrinskikh E , et al. Rapid MALDI-TOF molecular imaging: Instrument enhancements and their practical consequences. J Mass Spectrom, 2019.
doi: 10.1002/jms.4484 URL pmid: 31786817 |
[21] |
Prideaux B , ElNaggar MS, Zimmerman M, et al. Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling. Int J Mass Spectrom, 2015,377:699-708.
doi: 10.1016/j.ijms.2014.08.024 URL pmid: 26185484 |
[22] |
Prentice BM, Chumbley CW, Caprioli RM . Absolute quantification of rifampicin by MALDI imaging mass spectrometry using multiple TOF/TOF events in a single laser shot. J Am Soc Mass Spectrom, 2017,28(1):136-144.
doi: 10.1007/s13361-016-1501-2 URL pmid: 27655354 |
[23] |
Notari S, Mancone C, Sergi M , et al. Determination of antituberculosis drug concentration in human plasma by MALDI-TOF/TOF. IUBMB Life, 2010,62(5):387-393.
doi: 10.1002/iub.321 URL pmid: 20306514 |
[24] |
Gopal J, Muthu M, Chun SC , et al. State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics. Proteomics Clin Appl, 2015,9(5/6):469-481.
doi: 10.1002/prca.201400182 URL pmid: 25736343 |
[25] |
Soo PC, Horng YT, Chen AT , et al. Validation of nanodiamond-extracted CFP-10 antigen as a biomarker in clinical isolates of Mycobacterium tuberculosis complex in broth culture media. Tuberculosis (Edinb), 2015,95(5):620-624.
doi: 10.1016/j.tube.2015.05.008 URL pmid: 26071665 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||